
22.75 Delayed Data As of Jan 22 | ![]() Today’s Change | 14.42 Today|||52-Week Range 28.43 | -0.22% Year-to-Date |
The 2 analysts offering 12-month price forecasts for IRadimed Corp have a median target of 28.00, with a high estimate of 30.00 and a low estimate of 26.00. The median estimate represents a +23.08% increase from the last price of 22.75.
The current consensus among 2 polled investment analysts is to Buy stock in IRadimed Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.